A multicenter, retrospective, cross-sectional, real-world study of luspatercept in greek patients with transfusion dependent thalassemia
Latest Information Update: 12 Aug 2022
At a glance
- Drugs Luspatercept (Primary)
- Indications Beta-thalassaemia
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 12 Aug 2022 New trial record
- 17 Jun 2022 Results (Data cut-off date was 31-1-2022) presented at the 27th Congress of the European Haematology Association.